Efforts to take down the medical device tax have been repeatedly scrutinized by critics that paint repeal efforts as disingenuous or misguided, most recently in an LA Times editorial calling on the industry to defend its logic.
AdvaMed
AdvaMed’s J.C. Scott named as a “top lobbyist”
AdvaMed’s government affairs guru J.C. Scott has been named a "top lobbyist" by CEO Update, a publication that covers the trade association industry.
Scott received praised by the publication for his work on efforts to repeal the medical device tax,. He was one of only two healthcare related lobbyists on the list.
Medical device tax: AdvaMed takes the repeal fight to the people
Medical device tax repeal bill gains enough co-sponsors to pass House
Representatives in the U.S. House are set to repeat their vote to repeal the medical device tax, now that a bill to do away with the 2.3% sales levy has enough legislators behind it to ensure passage in the lower chamber.
The "Protect Medical Innovation Act of 2013," co-sponsored by Reps. Erik Paulsen (R-Minn.) and Ron Kind (D-Wis.), garnered 218 signatures from the duo’s House colleagues. The measure would repeal the medical device tax, retroactive to Dec. 31, 2012. It’s slated for an airing before the House Way’s & Means Committee this year.
Medical device lobbying chiefs rally in defense of medtech tax repeal
Leaders of medical device lobbying groups joined forces this week to refute a New York Times editorial painting recent successes in the effort to repeal the device tax as "one industry’s hold on the Senate."
Device lobby “doubles down” on medical device tax repeal | MassDevice.com On Call
MASSDEVICE ON CALL — Medical device lobbying group AdvaMed unveiled its 2013 agenda, highlighting its efforts to "double down" on efforts to repeal the 2.3% medical device tax that took effect at the start of the year.
AdvaMed fights to keep user fees out of sequester cuts for FDA
The medical device industry doesn’t want user fees paid by industry to be included in a series of cuts slated for the FDA’s budget this week.
The federal watchdog agency will have $210 million, or about 5.1% of its $4.1 billion budget, cut from its 2013 budget March 1 as a result of sequestration, the bargain between the White House and Congress.
Included in those cuts are the user fees medical device and pharmaceutical companies pay in order to insure timely reviews of new drugs and devices.
Medical device tax: Medtech seeks state-level relief from federal levy
Medical device makers are looking to their state regulators to help offset the burden of a new federal tax.
National medtech lobby AdvaMed joined forces with the State Medical Technology Alliance, a network of state-based industry groups, to develop state-level regulatory policies that they believe "foster an environment of growth and patient access to the latest in medical innovation."
Senate follows House in launching medical device tax repeal bill
A bipartisan group of Senators today released a bill that would repeal the 2.3% medical device tax, closely following a parallel bill released in the House of Representatives yesterday.
Medical device makers face another tax fight in Puerto Rico
Puerto Rico officials backed down from a reduction in the country’s medical device tax, planning instead to extend a temporary increase for another year.
The 4% tax, originally imposed in 2010, was supposed to shrink each year and drop to 1% in 2016. Treasury officials instead announced plans to seek an extension of the 4% tax rate through 2017, a move that U.S. medical device lobby group AdvaMed "strongly opposes."
More competitive bidding compromises patient access, device makers say
Medical device industry lobbying group AdvaMed spoke out against an expansion to Medicare’s competitive bidding programs, warning that the changes may deprive patients of their preferred devices.
Some analysts have lauded the Centers for Medicare & Medicaid for efforts to bring down costs of healthcare supplies. CMS began piloting its expanded bidding program in 9 cities and plans to expand to 100 metro areas, according to the Washington Post.